Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-21

Clinical Trial Update: Efficacy of Marine By-product Hydrolysate on the Reduction of Atopic Dermatitis Symptoms [NA]

View source ↗

Summary

Completed clinical trial evaluating the efficacy of marine by-product hydrolysate in reducing Atopic Dermatitis symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Marine by-product hydrolysate

Snippet

Sponsor: Abyss Ingredients | Conditions: Atopic Dermatitis, Eczema | NA | Status: COMPLETED